Abstract
In the title compound, C15H17N3O, the aldehyde group is twisted relative to the quinoline group by17.6 (2)° due to the presence of a bulky piperazinyl group in the ortho position. The piperazine N atom attached to the aromatic ring is sp 3-hybridized and the dihedral angle between the mean planes through the the six piperazine ring atoms and through the quinoline ring system is 40.59 (7)°. Both piperazine substituents are in equatorial positions.
Keywords: crystal structure, quinolines, piperazines
Related literature
For biological activity of quinoline derivatives, see: Nasveld et al. (2005 ▸); Eswaran et al. (2009 ▸); Leatham et al. (1983 ▸); Muruganantham et al. (2004 ▸); Maguire et al. (1994 ▸); Wilson et al. (1992 ▸); Strekowski et al. (1991 ▸). For photonic and electronic properties of poly-substituted quinolines, see: Gyoten et al. (2003 ▸).
Experimental
Crystal data
C15H17N3O
M r = 255.32
Monoclinic,
a = 12.3282 (4) Å
b = 5.8935 (2) Å
c = 18.9202 (7) Å
β = 103.591 (2)°
V = 1336.18 (8) Å3
Z = 4
Cu Kα radiation
μ = 0.65 mm−1
T = 296 K
0.28 × 0.26 × 0.24 mm
Data collection
Bruker APEXII CCD diffractometer
Absorption correction: multi-scan (SADABS; Bruker, 2009 ▸) T min = 0.838, T max = 0.859
9762 measured reflections
2181 independent reflections
1859 reflections with I > 2σ(I)
R int = 0.048
Refinement
R[F 2 > 2σ(F 2)] = 0.054
wR(F 2) = 0.162
S = 1.06
2181 reflections
173 parameters
H-atom parameters constrained
Δρmax = 0.22 e Å−3
Δρmin = −0.24 e Å−3
Data collection: APEX2 (Bruker, 2009 ▸); cell refinement: APEX2 and SAINT-Plus (Bruker, 2009 ▸); data reduction: SAINT-Plus and XPREP (Bruker, 2009 ▸); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▸); molecular graphics: Mercury (Macrae et al., 2008 ▸); software used to prepare material for publication: SHELXL97.
Supplementary Material
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989015020186/gk2647Isup3.cml
. DOI: 10.1107/S2056989015020186/gk2647fig1.tif
Molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
CCDC reference: 1433198
Additional supporting information: crystallographic information; 3D view; checkCIF report
Acknowledgments
The authors are thankful to the Institution of Excellence, Vijnana Bhavana, University of Mysore, Mysuru, for providing the single-crystal X-ray diffraction facility. RND, SS, PAS and DBAK are thankful to Tumkur University for providing laboratory facilities to carry out this work.
supplementary crystallographic information
S1. Introduction
Quinoline and its derivatives have been well known in pharmaceutical chemistry because of their wide spectrum of biological activities and their presence in naturally occurring compounds. They have been shown to possess antimalarial (Nasveld et al., 2005), antibiotic (Eswaran et al., 2009), anticancer (Denny et al., 1983), anti-inflammatory (Muruganantham et al., 2004), antihypertensive (Maguire et al., 1994), tyrokinase PDGF-RTK inhibition (Wilson et al., 1992) and anti-HIV properties (Strekowski et al., 1991). In addition, polysubstituted quinoline can achieve hierchical self-assembly into variety of meso and nano structures with enhanced photonic and electronic properties (Gyoten et al., 2003). In this view the title compound was synthesized to study its crystal structure.
S2. Experimental
S2.1. Synthesis and crystallization
2-Chloroquinoline-3-carbaldehyde (0.42 g, 0.00351 mmol), N-methyl piperazine (0.14 g, 0.00351 mmol) and anhydrous K2CO3 (1.0 g, 0.002920 mmol) were refluxed for 24 hrs in DMF. The progress of the reaction was monitored by thin layer chromatography. After the completion of the reaction, the reaction mixture was poured into water and extracted to ethyl acetate. The organic layer was washed with water, dried and concentrated under vacuum using rotary evaporator. Single crystals of the title compound were obtained by slow evaporation of the ethyl acetate solution at room temperature (27oC).
S2.2. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1. All H atoms were positioned with idealized geometry using a riding model with C—H = 0.93-0.97 Å. All H atoms were refined with isotropic displacement parameters (set to 1.2 times of the Ueq of the parent C atom).
S3. Results and discussion
The crystal packing of the compound does not feature any specific strong or weak intermolecular interactions.
Figures
Fig. 1.

Molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
Crystal data
| C15H17N3O | Prism |
| Mr = 255.32 | Dx = 1.269 Mg m−3 |
| Monoclinic, P21/n | Melting point: 384 K |
| Hall symbol: -P 2yn | Cu Kα radiation, λ = 1.54178 Å |
| a = 12.3282 (4) Å | Cell parameters from 143 reflections |
| b = 5.8935 (2) Å | θ = 3.9–64.5° |
| c = 18.9202 (7) Å | µ = 0.65 mm−1 |
| β = 103.591 (2)° | T = 296 K |
| V = 1336.18 (8) Å3 | Prism, colourless |
| Z = 4 | 0.28 × 0.26 × 0.24 mm |
| F(000) = 544 |
Data collection
| Bruker APEXII CCD diffractometer | 2181 independent reflections |
| Radiation source: fine-focus sealed tube | 1859 reflections with I > 2σ(I) |
| Graphite monochromator | Rint = 0.048 |
| phi and φ scans | θmax = 64.5°, θmin = 3.9° |
| Absorption correction: multi-scan (SADABS; Bruker, 2009) | h = −14→14 |
| Tmin = 0.838, Tmax = 0.859 | k = −6→6 |
| 9762 measured reflections | l = −21→21 |
Refinement
| Refinement on F2 | Primary atom site location: structure-invariant direct methods |
| Least-squares matrix: full | Secondary atom site location: difference Fourier map |
| R[F2 > 2σ(F2)] = 0.054 | Hydrogen site location: inferred from neighbouring sites |
| wR(F2) = 0.162 | H-atom parameters constrained |
| S = 1.06 | w = 1/[σ2(Fo2) + (0.1151P)2 + 0.0654P] where P = (Fo2 + 2Fc2)/3 |
| 2181 reflections | (Δ/σ)max < 0.001 |
| 173 parameters | Δρmax = 0.22 e Å−3 |
| 0 restraints | Δρmin = −0.24 e Å−3 |
Special details
| Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes. |
| Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| N1 | 0.44347 (10) | 0.7887 (2) | 0.60405 (6) | 0.0446 (4) | |
| N2 | 0.31637 (10) | 0.4894 (2) | 0.58318 (6) | 0.0443 (4) | |
| N3 | 0.15374 (11) | 0.2821 (2) | 0.46867 (7) | 0.0492 (4) | |
| O1 | 0.33529 (13) | 0.4038 (3) | 0.79890 (7) | 0.0800 (5) | |
| C1 | 0.38623 (12) | 0.6362 (3) | 0.63074 (7) | 0.0415 (4) | |
| C2 | 0.39605 (12) | 0.6082 (3) | 0.70773 (8) | 0.0435 (4) | |
| C3 | 0.46317 (13) | 0.7537 (3) | 0.75426 (8) | 0.0456 (4) | |
| H3 | 0.4690 | 0.7410 | 0.8040 | 0.055* | |
| C4 | 0.52382 (12) | 0.9229 (3) | 0.72789 (8) | 0.0429 (4) | |
| C5 | 0.59503 (14) | 1.0786 (3) | 0.77313 (9) | 0.0517 (5) | |
| H5 | 0.6035 | 1.0718 | 0.8232 | 0.062* | |
| C6 | 0.65119 (15) | 1.2380 (3) | 0.74416 (10) | 0.0571 (5) | |
| H6 | 0.6980 | 1.3397 | 0.7744 | 0.068* | |
| C7 | 0.63874 (16) | 1.2497 (3) | 0.66853 (10) | 0.0580 (5) | |
| H7 | 0.6768 | 1.3606 | 0.6490 | 0.070* | |
| C8 | 0.57153 (14) | 1.1003 (3) | 0.62334 (9) | 0.0516 (5) | |
| H8 | 0.5648 | 1.1094 | 0.5734 | 0.062* | |
| C9 | 0.51232 (12) | 0.9326 (3) | 0.65156 (8) | 0.0430 (4) | |
| C10 | 0.19665 (13) | 0.5037 (3) | 0.58101 (8) | 0.0477 (4) | |
| H10A | 0.1659 | 0.6413 | 0.5560 | 0.057* | |
| H10B | 0.1861 | 0.5100 | 0.6302 | 0.057* | |
| C11 | 0.13648 (13) | 0.3007 (3) | 0.54226 (9) | 0.0517 (5) | |
| H11A | 0.1635 | 0.1642 | 0.5694 | 0.062* | |
| H11B | 0.0573 | 0.3142 | 0.5399 | 0.062* | |
| C12 | 0.27299 (14) | 0.2697 (3) | 0.47221 (9) | 0.0522 (5) | |
| H12A | 0.2846 | 0.2582 | 0.4234 | 0.063* | |
| H12B | 0.3038 | 0.1347 | 0.4988 | 0.063* | |
| C13 | 0.33266 (14) | 0.4768 (3) | 0.50926 (8) | 0.0516 (5) | |
| H13A | 0.4117 | 0.4670 | 0.5106 | 0.062* | |
| H13B | 0.3031 | 0.6123 | 0.4824 | 0.062* | |
| C14 | 0.09682 (18) | 0.0831 (4) | 0.43236 (9) | 0.0660 (6) | |
| H14A | 0.1106 | 0.0708 | 0.3846 | 0.099* | |
| H14B | 0.0181 | 0.0973 | 0.4285 | 0.099* | |
| H14C | 0.1242 | −0.0501 | 0.4600 | 0.099* | |
| C15 | 0.34545 (14) | 0.4132 (3) | 0.73732 (9) | 0.0561 (5) | |
| H15 | 0.3201 | 0.2913 | 0.7067 | 0.067* |
Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| N1 | 0.0470 (7) | 0.0482 (8) | 0.0386 (7) | −0.0039 (6) | 0.0102 (6) | 0.0002 (5) |
| N2 | 0.0423 (7) | 0.0538 (9) | 0.0381 (7) | −0.0054 (6) | 0.0119 (5) | −0.0038 (6) |
| N3 | 0.0541 (8) | 0.0505 (9) | 0.0400 (7) | −0.0114 (6) | 0.0047 (6) | 0.0021 (6) |
| O1 | 0.0885 (10) | 0.1024 (13) | 0.0487 (8) | −0.0299 (8) | 0.0151 (7) | 0.0178 (7) |
| C1 | 0.0400 (8) | 0.0462 (9) | 0.0389 (8) | 0.0020 (6) | 0.0102 (6) | 0.0015 (6) |
| C2 | 0.0408 (8) | 0.0503 (10) | 0.0392 (8) | 0.0025 (6) | 0.0088 (6) | 0.0038 (7) |
| C3 | 0.0456 (9) | 0.0556 (10) | 0.0348 (8) | 0.0055 (7) | 0.0076 (6) | 0.0042 (7) |
| C4 | 0.0402 (8) | 0.0467 (9) | 0.0407 (8) | 0.0049 (6) | 0.0077 (6) | 0.0001 (6) |
| C5 | 0.0529 (10) | 0.0568 (11) | 0.0431 (8) | 0.0002 (8) | 0.0064 (7) | −0.0061 (7) |
| C6 | 0.0583 (10) | 0.0557 (11) | 0.0549 (10) | −0.0102 (8) | 0.0086 (8) | −0.0100 (8) |
| C7 | 0.0640 (11) | 0.0530 (11) | 0.0576 (10) | −0.0139 (8) | 0.0155 (8) | −0.0007 (8) |
| C8 | 0.0574 (10) | 0.0544 (11) | 0.0439 (8) | −0.0055 (8) | 0.0142 (7) | 0.0014 (7) |
| C9 | 0.0427 (8) | 0.0458 (10) | 0.0402 (8) | 0.0020 (6) | 0.0090 (6) | −0.0002 (6) |
| C10 | 0.0450 (9) | 0.0568 (11) | 0.0420 (8) | −0.0011 (7) | 0.0117 (6) | 0.0002 (7) |
| C11 | 0.0481 (9) | 0.0603 (11) | 0.0465 (9) | −0.0097 (7) | 0.0108 (7) | 0.0025 (7) |
| C12 | 0.0614 (10) | 0.0561 (11) | 0.0402 (8) | −0.0041 (7) | 0.0143 (7) | −0.0042 (7) |
| C13 | 0.0513 (9) | 0.0644 (11) | 0.0424 (8) | −0.0112 (8) | 0.0180 (7) | −0.0056 (7) |
| C14 | 0.0820 (13) | 0.0605 (12) | 0.0491 (10) | −0.0239 (9) | 0.0026 (9) | 0.0008 (8) |
| C15 | 0.0567 (10) | 0.0634 (12) | 0.0449 (9) | −0.0096 (8) | 0.0050 (7) | 0.0107 (8) |
Geometric parameters (Å, º)
| N1—C1 | 1.315 (2) | C6—H6 | 0.9300 |
| N1—C9 | 1.375 (2) | C7—C8 | 1.364 (3) |
| N2—C1 | 1.391 (2) | C7—H7 | 0.9300 |
| N2—C13 | 1.4607 (18) | C8—C9 | 1.406 (2) |
| N2—C10 | 1.4693 (19) | C8—H8 | 0.9300 |
| N3—C14 | 1.454 (2) | C10—C11 | 1.505 (2) |
| N3—C12 | 1.458 (2) | C10—H10A | 0.9700 |
| N3—C11 | 1.461 (2) | C10—H10B | 0.9700 |
| O1—C15 | 1.202 (2) | C11—H11A | 0.9700 |
| C1—C2 | 1.442 (2) | C11—H11B | 0.9700 |
| C2—C3 | 1.361 (2) | C12—C13 | 1.510 (2) |
| C2—C15 | 1.479 (2) | C12—H12A | 0.9700 |
| C3—C4 | 1.406 (2) | C12—H12B | 0.9700 |
| C3—H3 | 0.9300 | C13—H13A | 0.9700 |
| C4—C5 | 1.411 (2) | C13—H13B | 0.9700 |
| C4—C9 | 1.419 (2) | C14—H14A | 0.9600 |
| C5—C6 | 1.357 (3) | C14—H14B | 0.9600 |
| C5—H5 | 0.9300 | C14—H14C | 0.9600 |
| C6—C7 | 1.404 (3) | C15—H15 | 0.9300 |
| C1—N1—C9 | 118.40 (12) | N2—C10—C11 | 110.18 (13) |
| C1—N2—C13 | 116.58 (12) | N2—C10—H10A | 109.6 |
| C1—N2—C10 | 116.60 (12) | C11—C10—H10A | 109.6 |
| C13—N2—C10 | 109.84 (11) | N2—C10—H10B | 109.6 |
| C14—N3—C12 | 110.53 (15) | C11—C10—H10B | 109.6 |
| C14—N3—C11 | 110.40 (13) | H10A—C10—H10B | 108.1 |
| C12—N3—C11 | 109.34 (12) | N3—C11—C10 | 111.00 (13) |
| N1—C1—N2 | 118.89 (12) | N3—C11—H11A | 109.4 |
| N1—C1—C2 | 122.74 (14) | C10—C11—H11A | 109.4 |
| N2—C1—C2 | 118.32 (13) | N3—C11—H11B | 109.4 |
| C3—C2—C1 | 118.36 (14) | C10—C11—H11B | 109.4 |
| C3—C2—C15 | 119.41 (14) | H11A—C11—H11B | 108.0 |
| C1—C2—C15 | 121.90 (15) | N3—C12—C13 | 110.89 (14) |
| C2—C3—C4 | 120.69 (14) | N3—C12—H12A | 109.5 |
| C2—C3—H3 | 119.7 | C13—C12—H12A | 109.5 |
| C4—C3—H3 | 119.7 | N3—C12—H12B | 109.5 |
| C3—C4—C5 | 123.55 (14) | C13—C12—H12B | 109.5 |
| C3—C4—C9 | 117.08 (14) | H12A—C12—H12B | 108.0 |
| C5—C4—C9 | 119.36 (15) | N2—C13—C12 | 108.90 (13) |
| C6—C5—C4 | 120.59 (15) | N2—C13—H13A | 109.9 |
| C6—C5—H5 | 119.7 | C12—C13—H13A | 109.9 |
| C4—C5—H5 | 119.7 | N2—C13—H13B | 109.9 |
| C5—C6—C7 | 120.09 (16) | C12—C13—H13B | 109.9 |
| C5—C6—H6 | 120.0 | H13A—C13—H13B | 108.3 |
| C7—C6—H6 | 120.0 | N3—C14—H14A | 109.5 |
| C8—C7—C6 | 120.80 (16) | N3—C14—H14B | 109.5 |
| C8—C7—H7 | 119.6 | H14A—C14—H14B | 109.5 |
| C6—C7—H7 | 119.6 | N3—C14—H14C | 109.5 |
| C7—C8—C9 | 120.59 (15) | H14A—C14—H14C | 109.5 |
| C7—C8—H8 | 119.7 | H14B—C14—H14C | 109.5 |
| C9—C8—H8 | 119.7 | O1—C15—C2 | 123.51 (18) |
| N1—C9—C8 | 118.78 (13) | O1—C15—H15 | 118.2 |
| N1—C9—C4 | 122.64 (14) | C2—C15—H15 | 118.2 |
| C8—C9—C4 | 118.56 (15) |
Footnotes
Supporting information for this paper is available from the IUCr electronic archives (Reference: GK2647).
References
- Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
- Eswaran, S., Adhikari, A. V. & Shetty, N. S. (2009). Eur. J. Med. Chem. 44, 4637–4647. [DOI] [PubMed]
- Gyoten, M., Nagaya, H., Fukuda, S., Ashida, Y. & Kawano, Y. (2003). Chem. Pharm. Bull. 51, 122–133. [DOI] [PubMed]
- Leatham, P. A., Bird, H. A., Wright, V., Seymour, D. & Gordon, A. (1983). Eur. J. Rheumatol. Inflamm. 6, 209–211. [PubMed]
- Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470.
- Maguire, M. P., Sheets, K. R., McVety, K., Spada, A. P. & Zilberstein, A. (1994). J. Med. Chem. 37, 2129–2137. [DOI] [PubMed]
- Muruganantham, N., Sivakumar, R., Anbalagan, N., Gunasekaran, V. & Leonard, J. T. (2004). Biol. Pharm. Bull. 27, 1683–1687. [DOI] [PubMed]
- Nasveld, P. & Kitchener, S. (2005). Trans. R. Soc. Trop. Med. Hyg. 99, 2–5. [DOI] [PubMed]
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Strekowski, L., Mokrosz, J. L., Honkan, V. A., Czarny, A., Cegla, M. T., Wydra, R. L., Patterson, S. E. & Schinazi, R. F. (1991). J. Med. Chem. 34, 1739–1746. [DOI] [PubMed]
- Wilson, W. D., Zhao, M., Patterson, S. E., Wydra, R. L., Janda, L. & Strekowski, L. (1992). J. Med. Chem. Res. 2, 102–110.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015020186/gk2647Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989015020186/gk2647Isup3.cml
. DOI: 10.1107/S2056989015020186/gk2647fig1.tif
Molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
CCDC reference: 1433198
Additional supporting information: crystallographic information; 3D view; checkCIF report
